Evaluation of hypolipidemic effect of stem part of Berberis aristata in Type 2 diabetes mellitus patients as add on therapy

Journal Title: National Journal of Physiology, Pharmacy and Pharmacology - Year 2017, Vol 7, Issue 11

Abstract

Background: Diabetes mellitus (DM) is one of the oldest common metabolic disorders characterized by hyperglycemia, hyperlipidemia, negative nitrogen balance, and ketonemia. It is a one of the most important pathological conditions associated with dyslipidemia that affects the whole body system. Several types of DM exist and result by a complex interaction of genes and drugs, gestational diabetes, environmental factors such as stress and sedentary lifestyle choices. DM is the leading cause of end-stage renal disease, coronary artery disease, cerebrovascular disease, nontraumatic lower extremity amputations, and adult blindness. Aims and Objectives: This study was conducted to evaluate the hypolipidemic effect of stem part of Berberis aristata in patients of Type 2 DM with dyslipidemia as add on therapy. Materials and Methods: A prospective randomized open parallel group study was conducted in total 90 patients having high fasting blood sugar (FBS) and dyslipidemia of either sex in the age group of 30-60 years attending of outpatient/indoor Department of Medicine of Muzaffarnagar Medical College and Hospital, Muzaffarnagar, Uttar Pradesh, India. A total of 103 each Group 1 (N = 30) was taken as control while Group 2 (N = 30) and Group 3 (N = 30) was taken as study group who had received 1.5 and 3 g of B. aristata, respectively, as add on therapy along with their conventional antidiabetic and antihyperlipidemic (in certain number of patients) treatment. During the study, 13 patients (8 male and 5 female) did not complete the study and reason of premature withdrawal included protocol violation. Results: In our study, there were a statistically a highly significant improvement and stabilization of glycemic control in test Groups 2 and 3 when compared with control group (P < 0.01). In Groups 2 and 3, reduction of FBS level from 1 month onward. The mean high density lipoprotein level improved significantly in the Group 2 (P < 0.01) and highly significantly in Group 3 (P < 0.001) as compared to control. The mean total cholesterol level decreased no significantly in the Group 2 (P > 0.05) and highly significant in Group 3 (P < 0.001) as compared to control. The mean triglyceride level decreased highly significantly in the Group 2 and Group 3 (P < 0.001) as compared to control. The mean low density lipoprotein level decreased highly significant in the Group 2 and Group 3 (P < 0.001) as compared to control. Conclusion: It can be concluded that B. aristata as an add on therapy in Type 2 DM patients has a beneficial role with regard to the hyperglycemia and dyslipidemia very safe as no major side effects were observed affecting morbidity and mortality. Hence, B. aristata as an add on therapy could represent a good treatment option before initiating insulin and hypolipidemic therapy in diabetic patient with suboptional glycemic and lipideimic control to avoid unwanted adverse effects and can cut down cost of treatment.

Authors and Affiliations

Rajeev Kumar Sharma, Bhawana Sharma, Meenakshi Jindal, Arvind Kumar Gupta, Ramesh Kunwar, Suman Lata, Awadhesh Kumar Yadav

Keywords

Related Articles

&nbsp;Protective role of Vitamin E: on diazinon-induced hepatotoxicity by biochemical and histological alterations in Wistar rats

&nbsp;Background: Pesticides are developed for welfare of human beings, though they impose and challenge our existence by their longterm toxicity. Organophosphates such as diazinon contain phosphorus and derivatives of...

The activity of metabolic enzymes in the saliva of lung cancer patients

Background: So far, optimization problems for diagnostics and prognostication aids have been still relevant for lung cancer as a leader in the structure of cancers. Aims and Objectives: A search for regularities of chang...

&nbsp;Variation in pulmonary function tests parameters in different phases of menstrual cycle in healthy female medical students

&nbsp;Background: Menstrual cycle is a physiological process that occurs in women. It is characterized by periodic vaginal bleeding owing to the shedding of uterine mucosa, which has its own effect on various systems an...

Evaluating the clinical applications of visual evoked potentials in patients presenting with visual dysfunctions - A retrospective study

Background: The clinical applicability of visual evoked potential (VEP) tests has been progressively extending in neuro-ophthalmological workups. The role in monitoring and follow-ups are emerging as even more useful app...

&nbsp;Hypolipidemic effect of Tamarindus indica L fruit on Triton X-100-induced hyperlipidemia in Wistar rats

&nbsp;Background: Tamarindus indica L is widely used as a traditional medicine. In Indonesia T. indica L is commonly used to treat gastritis, rheumatism, constipation, and fever. Aims and Objective: The purpose of this...

Download PDF file
  • EP ID EP292064
  • DOI 10.5455/njppp.2017.7.0517510062017
  • Views 58
  • Downloads 0

How To Cite

Rajeev Kumar Sharma, Bhawana Sharma, Meenakshi Jindal, Arvind Kumar Gupta, Ramesh Kunwar, Suman Lata, Awadhesh Kumar Yadav (2017). Evaluation of hypolipidemic effect of stem part of Berberis aristata in Type 2 diabetes mellitus patients as add on therapy. National Journal of Physiology, Pharmacy and Pharmacology, 7(11), 1159-1169. https://europub.co.uk./articles/-A-292064